Title:
ナルトレキソンの徐放型配合物
Document Type and Number:
Japanese Patent JP5921513
Kind Code:
B2
Abstract:
A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition.
Inventors:
Anthony A. McKinney
Gary Dee Trefson
Richard Saltello
Sare Elise Dunzo
Gary Dee Trefson
Richard Saltello
Sare Elise Dunzo
Application Number:
JP2013217496A
Publication Date:
May 24, 2016
Filing Date:
October 18, 2013
Export Citation:
Assignee:
Orexigen Therapeutics, Inc.
International Classes:
A61K31/485; A61K31/135; A61P3/04; A61P43/00
Domestic Patent References:
| JP5478245B2 |
Foreign References:
| WO2004096201A1 |
Attorney, Agent or Firm:
Yasuhiko Murayama
Masatake Shiga
Takashi Watanabe
Shinya Mitsuhiro
Masatake Shiga
Takashi Watanabe
Shinya Mitsuhiro